Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
212,883,456
-
Total 13F shares
-
19,366,898
-
Share change
-
+486,233
-
Total reported value
-
$85,218,931
-
Put/Call ratio
-
92%
-
Price per share
-
$4.40
-
Number of holders
-
60
-
Value change
-
+$2,811,165
-
Number of buys
-
33
-
Number of sells
-
21
Institutional Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q2 2019
As of 30 Jun 2019 OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) had 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 19,366,898 shares of stock of the company.
Largest 10 holders included SUMMER ROAD LLC, Opaleye Management Inc., Versant Venture Management, LLC, Man Group plc, VANGUARD GROUP INC, DELTEC ASSET MANAGEMENT LLC, FMR LLC, SV Health Investors, LLC, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 60 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.